Search the Newsreel

MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside

MDxHealth SA's average stock price target has been reduced from $2.8 to $2.2 by analysts, with individual forecasts ranging from $1 to $4. This updated target suggests a potential upside of approximately 376% from its recent closing price. The consensus rating for the stock …

MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic De-Risking

MDxHealth SA (MDXH) achieved its largest quarter-over-quarter revenue acceleration in Q2 2026, increasing 14% sequentially, while eliminating a $10.4 million liability. The company strengthened its balance sheet with a $20 million financing and reaffirmed its full-year 2026 revenue guidance of $110 million to $115 …

MDXH Looks 79.0% Undervalued on GF Value™ but Faces Value Trap Warning

MDxHealth SA (MDXH) is currently trading at a significant discount to its GF Value, suggesting a 79.0% undervaluation. However, investors are cautioned due to the company's unprofitability, negative cash flow, and a low GF Score™ of 49/100, indicating financial weakness despite strong growth metrics. …

MDxHealth ADR earnings missed, revenue topped estimates

MDxHealth ADR (NASDAQ: MDXH) reported its second-quarter earnings, missing analyst estimates for EPS but exceeding revenue expectations. The company provided a full-year 2026 revenue guidance that falls within the analyst consensus. Despite topping revenue estimates, MDxHealth ADR's stock has seen significant declines over the …

MDxHealth (NASDAQ: MDXH) lifts Q2 2026 revenue 16% but posts deeper loss

Mdxhealth Sells 44M Shares for $20M Gross as Q2 Net Loss Hits $9.5M

MDxHealth (MDXH) sells 44M shares, lifting total stock to 95.4M

MDxHealth SA completed a Registered Direct Offering, issuing over 44 million ordinary shares at $0.454 per share to institutional investors, raising approximately $20.0 million in net proceeds. These funds will be used for working capital, product development, and expanding commercialization activities. Following this offering, …

Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026

MDxHealth reported Q2 2026 revenue of $27.2 million, exceeding Wall Street estimates of $25.89 million, leading to a 33.12% jump in after-hours trading despite a slight EPS miss. The company saw a 16% year-over-year revenue increase and expects full-year 2026 revenue between $110 million …

MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates

MDxHealth SA (MDXH) reported a Q2 loss of $0.18 per share, missing the Zacks Consensus Estimate of a $0.12 loss. However, the company surpassed revenue estimates with $27.21 million, exceeding the $26.6 million expectation. Despite beating revenue, the stock has significantly underperformed the S&P …

Mdxhealth Reports Second Quarter 2026 Financial Results

Mdxhealth reported a 16% increase in second-quarter 2026 revenue, reaching $27.2 million, driven by strong recovery in its tissue-based business and integration of ExoDx. The company reaffirmed its 2026 revenue guidance of $110-115 million and expects to return to positive adjusted EBITDA by the …

MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MDxHealth SA (MDXH), indicating a current earnings forecast score of 7.67, ranking 275th in its industry. Analysts have set an average price target of $7.00, with most recommending a "Buy" trend. The company's expected revenue for the …

MDxHealth SA (0O8G.L) stock price, news, quote and history

This page on Yahoo Finance provides the stock price, news, quote, and historical data for MDxHealth SA (0O8G.L). As of December 15th, the stock was trading at 3.0198 EUR, down 5.64% for the day. The page also features trending tickers and market indices.

Mdxhealth schedules live Q&A on second-quarter results Aug. 13

Mdxhealth (NASDAQ: MDXH) will release its second-quarter 2026 financial results after market close on Thursday, August 13, 2026. The company will host a conference call and webcast with a live Q&A session at 4:30 PM ET / 22:30 CET, with a replay available on …

Mdxhealth to Release Second Quarter 2026 Financial Results on August 13

Mdxhealth SA (NASDAQ: MDXH) announced it will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026. The company will host a conference call with live Q&A on the same day at 4:30 PM ET / 10:30 PM CET …

MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of MDxHealth SA (MDXH), covering its stock price, support and resistance levels, and various technical indicators and moving averages. As of July 29, 2026, MDXH has a price momentum score of 4.52 and is trading between a resistance …

MDxHealth SA Revenue Breakdown – NASDAQ:MDXH

MDxHealth SA (NASDAQ: MDXH) generated $107.88 million USD in revenue last year, primarily from its Tissue-based segment, which contributed $81.49 million USD. The majority of its revenue, $107.88 million USD, originated from the United States, Europe, and the Rest of the World.

MDXH|MDxHealth SA|Price:0.400|Chg%:-0.011

This article provides a comprehensive stock analysis of MDxHealth SA (MDXH), highlighting its strong fundamentals and high growth potential despite recent weak market performance. The company is considered fairly valued within the Biotechnology & Medical Research industry and shows high institutional ownership. Analysts have …

Mdxhealth Has Until Jan. 19 to Regain Compliance or May Face Delisting

Mdxhealth (NASDAQ: MDXH) received a Nasdaq notification on July 20, 2026, stating that the company no longer complies with the US$35 million minimum market value requirement. This follows a previous notice regarding non-compliance with the $1.00 minimum bid price. Mdxhealth has been given 180 …

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency

MDxHealth SA (EBR:MDXH) has received a notification from Nasdaq indicating that it is no longer in compliance with the minimum market value of listed securities requirement for continued listing. The company has 180 calendar days to regain compliance, which means its market value must …

MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of MDxHealth SA (MDXH), noting its current financial score of 7.19, which ranks it 139 out of 386 in the Biotechnology & Medical Research industry. The company is described as stable with high operating efficiency, reporting a …

Mdxhealth (NASDAQ: MDXH) warned on US$35M Nasdaq market value rule

Mdxhealth (NASDAQ: MDXH) has received a warning from Nasdaq for failing to meet the minimum Market Value of Listed Securities requirement of US$35 million. The company has 180 calendar days, until January 19, 2027, to regain compliance by maintaining a market value of at …

mdxhealth Receives Nasdaq Notice of Minimum Market Value Deficiency

Mdxhealth SA has received a Nasdaq notification for non-compliance with the minimum market value requirement, following an earlier notice regarding its failure to meet the minimum bid price. The company now has 180 days, until January 19, 2027, to regain compliance by maintaining a …

MDxHealth SA (MDXH) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides information on MDxHealth SA (MDXH) stock, including its current trading price, market capitalization, and dividend history. It states that the company has not distributed any dividends over the past five years. The page outlines various financial and company profile sections available …

MDxHealth SA (MDXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for MDxHealth SA (MDXH), detailing its regional revenue contribution for FY2023. The United States of America accounts for the vast majority of revenue at 99.31%, with Europe contributing 0.68% and the rest of the world 0.01%. Information regarding …

mdxhealth flags Nasdaq notice over US$35 million market value deficiency

MDxHealth has received a Nasdaq notice for failing to meet the minimum US$35 million market value requirement, specifically Listing Rule 5550(b)(2), due to 30 consecutive business days of non-compliance between June 1 and July 17, 2026. The company currently remains listed but has until …

MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk

The article provides a risk assessment for MDxHealth SA (MDXH), noting its current score is 2.78, ranking 188 out of 386 in the Biotechnology & Medical Research industry. The company's beta of 0.56 indicates it tends to underperform in up markets but has smaller …

TD Cowen cuts MDxHealth stock price target on Medicare dispute

MDxHealth (MDXH) Q1 Loss Near US$8.9 Million Reinforces Bearish Profitability Concerns

MDXH Sets New Revenue Forecast Excluding Resolve, Anticipates St

MDxHealth (MDXH) Q1 2026 Earnings Transcript

Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-Term